Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
About this trial
This is an observational trial for Adenocarcinoma of the Gastroesophageal Junction focused on measuring adenocarcinoma of the gastroesophageal junction, recurrent gastric cancer, stage IV gastric cancer, adenocarcinoma of the stomach, adenocarcinoma of the esophagus, recurrent esophageal cancer, stage I esophageal cancer, stage II esophageal cancer, stage III esophageal cancer, stage IV esophageal cancer, stage IA gastric cancer, stage IB gastric cancer, stage IIA gastric cancer, stage IIB gastric cancer, stage IIIA gastric cancer, stage IIIB gastric cancer, stage IIIC gastric cancer
Eligibility Criteria
DISEASE CHARACTERISTICS:
Must meet 1 of the following criteria:
Diagnosis of gastric or esophageal adenocarcinoma
- Diagnosed within the past 5 years
- May include gastro-esophageal junction tumor
- Spouse or relative of the patient
- Samples collected from the European Prospective Investigation of Cancer (EPIC) study
- Patients will be approached to participate in the study regardless of their current treatment being curative or palliative, medical or surgical, or if they are currently having follow-up clinical appointments
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Sites / Locations
- Cancer Research UK at Cambridge Research InstituteRecruiting